FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc., representing a labeling amendment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Zollinger-ellison Syndrome

Drugs mentioned

• PRILOSEC (Omeprazole magnesium)

Snippet

SUPPL AP for PRILOSEC (OMEPRAZOLE MAGNESIUM)